Skip to content
MedCompare

Acalabrutinib

Also known as Calquence (us)

Cancer & Oncology
Save $2,481/mo

Acalabrutinib is used to treat people with mantle cell lymphoma (MCL; a fast-growing cancer that begins in the cells of the immune system).

United States
$6,933
per month
India
$4,452
per month
You save
$2,481
36% cheaper in India
122.4K US scripts/yr$303.7M potential annual savings$848.6M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC26H23N7O2

SMILES: CC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5

Compare the price
US price$6,933per month
India price$4,452per month
You save$2,48136% less

Based on 30 units per month. US $231.11 vs India $148.40 per unit.

Total over 1 periodSave $2,481$6,933 → $4,452
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$14,887
Estimated travel cost
− $2,300
Net savings after travel
$12,587

Even after travel, you could come out ahead by about $12,587.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Acalabrutinib is filled about 122.4K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$848.6M
If sourced from India
$544.9M
Potential annual savings
$303.7M
−36%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.